Efficacy and Safety of Donepezil in Patients with Alzheimer’s Disease: Results of a Global, Multinational, Clinical Experience Study

By Boada-Rovira M.  

Drugs & Aging, Vol. 21, Iss. 1, 2004-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Tolerability of Ramipril 10 mg/day in High-Risk Cardiovascular Chinese Patients

By Wu N.   Zhu J.R.   Chen K.A.  

Clinical Drug Investigation, Vol. 22, Iss. 11, 2002-01 ,pp. : 771-781

Adis International

Access to resources Recommend Favorite

Enzastaurin 525 mg/day is the recommended dosage for patients with cancer, and it is well tolerated at dosages of up to 700 mg/day

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

A randomised, double-blind, comparison of the efficacy and safety of venlafaxine (75 to 150 mg/day) versus fluoxetine (20 mg/day) in depressed outpatients

By Salinas E.   Nicholas T.   Hackett D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 308-308

Elsevier

Access to resources Recommend Favorite